Fujifilm Holdings (TSE:4901), which lost out in March to Canon (NYSE:CAJ) in the race for Toshiba‘s (TYO:6502) medical device business, is still hot to trot on the mergers & acquisitions trail.
New COO Kenji Sukeno said the Japanese company is looking at pharmaceuticals and the regenerative medicine space.
“There are various deals on the table, though I can’t give details,” Kenji Sukeno told Reuters.
Toshiba granted Canon exclusive negotiating rights to buy Toshiba Medical for about $5.95 billion after a hotly contested auction that had Fujifilm leading the pack.
An embittered Fujifilm later questioned Toshiba on the timing of the deal, even before Toshiba managed to book the sale before the deal actually closed.
Material from Reuters was used in this report.
The post Fujufilm, jilted in Toshiba Medical sale, still hot to trot the M&A trail appeared first on MassDevice.